Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

R&D Restructurings Aim To Placate Investors While Pharma Waits For Results

Executive Summary

In response to poor R&D productivity and declining revenue as drug patents expire, Big Pharma companies have shrunk drastically to keep shareholders happy while they try to retool moribund R&D strategies.
Advertisement

Related Content

Sanofi Pulls Back On French Layoff Plans After Government Pressure
Swedish Boost For Life Sciences Innovation Resonates Around Europe
European Pharma In Cost-Cutting Mode: Actelion Axes 135 Positions, Sanofi Aims At French R&D Consolidation
We’re #8! PTO Ranks The Economic Power Of Pharma’s Patents
New $80 Million U.K. Asset-Centric Cancer Research Fund Set Up With EU, Charity Funding
Sanofi Avoids Patent Cliff For Now, Returns to Growing Sales And Profits In Third Quarter
Novartis Cuts 2,000 Jobs In Switzerland And U.S., Pricing Pressures To Blame
AstraZeneca Rebuilds R&D Amid Growing Near-Term Pressures
Despite Recent Setbacks At Pfizer, R&D Chief Is Optimistic About R&D Innovation
Despite Recent Setbacks At Pfizer, R&D Chief Is Optimistic About R&D Innovation

Topics

Advertisement
UsernamePublicRestriction

Register

PS053766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel